USRC Kidney Research
Quick facts
Marketed products
Phase 3 pipeline
- Ferric Citrate 1 GM Oral Tablet [AURYXIA] · Nephrology
Ferric citrate binds phosphate in the gastrointestinal tract to reduce serum phosphate levels in patients with chronic kidney disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: